Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Insulin sensitizers--drugs that increase sensitivity to insulin such as Avandia and Actos--could help lessen the risk of peripheral arterial disease (PAD) for those with type 2 diabetes, according to a new study.
That's great news for the 8 million Americans who are currently battling PAD, a disease that causes narrowing of the arteries, leading to decreased blood flow to the legs. It leads to pain, tingling and a slower rate of healing for wounds. Symptoms of the disease include pain after walking long distances, a shiny appearance to the skin on your legs, coldness or numbness of the legs and feet, and trouble walking.
http://diabeteshealth.com/read/2013...s-on-insulin-sensitizers-run-lower-pad-risk-/
That's great news for the 8 million Americans who are currently battling PAD, a disease that causes narrowing of the arteries, leading to decreased blood flow to the legs. It leads to pain, tingling and a slower rate of healing for wounds. Symptoms of the disease include pain after walking long distances, a shiny appearance to the skin on your legs, coldness or numbness of the legs and feet, and trouble walking.
http://diabeteshealth.com/read/2013...s-on-insulin-sensitizers-run-lower-pad-risk-/